1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. AgeX Therapeutics Inc (AGE)
  7. Quote


AgeX Therapeutics Stock Price

-0.0298 (-3.97%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 28,410
Bid Price
Ask Price
News -
Day High 0.75


52 Week Range


Day Low 0.7066
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
AgeX Therapeutics Inc AGE AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0298 -3.97% 0.7202 17:00:00
Open Price Low Price High Price Close Price Prev Close
0.72 0.7066 0.75 0.7202 0.75
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
118 28,410 $ 0.7324836 $ 20,810 - 0.71 - 3.06
Last Trade Time Type Quantity Stock Price Currency
17:00:00 100 $ 0.7202 USD


Draw Mode:

AgeX Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 27.32M 37.94M 21.46M $ 1.87M $ - -0.29 -3.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.08k 0.20%

more financials information »

AgeX Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AGE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.7660.83520.710.7638905145,140-0.0458-5.98%
1 Month0.84030.900.710.7982033121,755-0.1201-14.29%
3 Months1.031.070.710.86530179,322-0.3098-30.08%
6 Months1.251.770.711.1484,497-0.5298-42.38%
1 Year1.893.060.711.77173,416-1.17-61.89%
3 Years1.135.950.6662.28643,809-0.4098-36.27%
5 Years1.135.950.6662.28643,809-0.4098-36.27%

AgeX Therapeutics Description

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.

Your Recent History
AgeX Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.